135 related articles for article (PubMed ID: 19035904)
1. Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.
Sonpavde G; Sternberg CN
BJU Int; 2008 Nov; 102(9 Pt B):1354-60. PubMed ID: 19035904
[TBL] [Abstract][Full Text] [Related]
2. Novel agents for muscle-invasive and advanced urothelial cancer.
Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
[TBL] [Abstract][Full Text] [Related]
3. Current optimal chemotherapy for advanced urothelial cancer.
Sonpavde G; Galsky MD; Hutson TE
Expert Rev Anticancer Ther; 2008 Jan; 8(1):51-61. PubMed ID: 18095883
[TBL] [Abstract][Full Text] [Related]
4. The evolving role of chemotherapy in advanced urothelial cancer.
Calabrò F; Sternberg CN
Curr Opin Support Palliat Care; 2007 Oct; 1(3):180-6. PubMed ID: 18685360
[TBL] [Abstract][Full Text] [Related]
5. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Suzuki S; Nonomura K
Eur Urol; 2007 Oct; 52(4):1106-13. PubMed ID: 17367917
[TBL] [Abstract][Full Text] [Related]
6. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
Kollmannsberger C; Bokemeyer C
Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
8. Possible survival benefit of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin combination therapy (HD-MVAC) over conventional MVAC in metastatic urothelial carcinoma patients.
Inoue T; Obara T; Saito M; Kumazawa T; Yuasa T; Matuura S; Tsuchiya N; Satoh S; Habuchi T
Hinyokika Kiyo; 2007 Sep; 53(9):613-8. PubMed ID: 17933135
[TBL] [Abstract][Full Text] [Related]
9. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI; Stadler WM; Bajorin DF
BJU Int; 2008 Nov; 102(9 Pt B):1339-44. PubMed ID: 19035902
[TBL] [Abstract][Full Text] [Related]
10. Novel agents for advanced bladder cancer.
Sonpavde G; Elfiky AA; Rosenberg JE
Ther Adv Med Oncol; 2009 Jul; 1(1):37-50. PubMed ID: 21789112
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant systemic therapy for urological malignancies.
Sonpavde G; Sternberg CN
BJU Int; 2010 Jul; 106(1):6-22. PubMed ID: 20553475
[TBL] [Abstract][Full Text] [Related]
12. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
14. Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer.
Tsuchiya N; Inoue T; Narita S; Kumazawa T; Saito M; Obara T; Tsuruta H; Horikawa Y; Yuasa T; Satoh S; Habuchi T
J Urol; 2008 Dec; 180(6):2389-95. PubMed ID: 18930278
[TBL] [Abstract][Full Text] [Related]
15. Systemic chemotherapy options for metastatic bladder cancer.
Siefker-Radtke A
Expert Rev Anticancer Ther; 2006 Jun; 6(6):877-85. PubMed ID: 16761931
[TBL] [Abstract][Full Text] [Related]
16. Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
Yafi FA; Kassouf W
Expert Rev Anticancer Ther; 2009 Jun; 9(6):747-52. PubMed ID: 19496711
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for urological cancer : usefulness and feasibility of current protocols].
Hara I; Motoo Y
Hinyokika Kiyo; 2011 Mar; 57(3):151-2. PubMed ID: 21586888
[TBL] [Abstract][Full Text] [Related]
18. [Urological cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2009 Feb; 36(2):193-8. PubMed ID: 19223735
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Pu YS; Vogelzang NJ
BJU Int; 2008 Apr; 101(7):795-803. PubMed ID: 18070193
[No Abstract] [Full Text] [Related]
20. Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Heidenreich A
Eur Urol; 2008 Jul; 54(1):21-3. PubMed ID: 18262722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
